🇺🇸 FDA
Pipeline program

Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe

LPS16676

Approved small_molecule active

Quick answer

Dupilumab, dupilumab placebo, solution for injection in pre-filled syringe for Asthma is a Approved program (small_molecule) at Sanofi Pharma Bristol-Myers Squibb with 1 ClinicalTrials.gov record(s).

Program details

Company
Sanofi Pharma Bristol-Myers Squibb
Indication
Asthma
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials